Your browser doesn't support javascript.
loading
Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial.
McCurdy, Sandra; Nenninger, Ashley; Sheets, Amanda; Keedy, Kara; Lawrence, Laura; Quintas, Megan; Cammarata, Sue.
Afiliación
  • McCurdy S; Melinta Therapeutics, Morristown, NJ, USA. Electronic address: smccurdy@melinta.com.
  • Nenninger A; Melinta Therapeutics, Morristown, NJ, USA. Electronic address: ashley.nenninger@hologic.com.
  • Sheets A; Melinta Therapeutics, Morristown, NJ, USA. Electronic address: amanda.j.sheets@gmail.com.
  • Keedy K; Melinta Therapeutics, Morristown, NJ, USA. Electronic address: kara.keedy@aimmaxrx.com.
  • Lawrence L; Melinta Therapeutics, Morristown, NJ, USA. Electronic address: llawr0808@outlook.com.
  • Quintas M; Melinta Therapeutics, Morristown, NJ, USA. Electronic address: mquintas@artugentherapeutics.com.
  • Cammarata S; Melinta Therapeutics, Morristown, NJ, USA. Electronic address: scammarata@melinta.com.
Int J Infect Dis ; 97: 374-379, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32534142

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Comunitarias Adquiridas / Neumonía Bacteriana / Fluoroquinolonas / Moxifloxacino / Antibacterianos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Comunitarias Adquiridas / Neumonía Bacteriana / Fluoroquinolonas / Moxifloxacino / Antibacterianos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article